- Home
- ETON vs MVIS Comparison
ETON vs MVIS Comparison
Compare ETON & MVIS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ETON
- MVIS
- Stock Information
- Founded
- ETON 2017
- MVIS 1993
- Country
- ETON United States
- MVIS United States
- Employees
- ETON N/A
- MVIS N/A
- Industry
- ETON Biotechnology: Pharmaceutical Preparations
- MVIS Industrial Machinery/Components
- Sector
- ETON Health Care
- MVIS Technology
- Exchange
- ETON Nasdaq
- MVIS Nasdaq
- Market Cap
- ETON 329.8M
- MVIS 272.0M
- IPO Year
- ETON 2018
- MVIS 1996
- Fundamental
- Price
- ETON $14.55
- MVIS $1.16
- Analyst Decision
- ETON Strong Buy
- MVIS Buy
- Analyst Count
- ETON 3
- MVIS 4
- Target Price
- ETON $27.67
- MVIS $2.67
- AVG Volume (30 Days)
- ETON 235.8K
- MVIS 4.6M
- Earning Date
- ETON 05-08-2025
- MVIS 05-08-2025
- Dividend Yield
- ETON N/A
- MVIS N/A
- EPS Growth
- ETON N/A
- MVIS N/A
- EPS
- ETON N/A
- MVIS N/A
- Revenue
- ETON $39,011,000.00
- MVIS $4,696,000.00
- Revenue This Year
- ETON $92.33
- MVIS $486.46
- Revenue Next Year
- ETON $52.62
- MVIS $137.89
- P/E Ratio
- ETON N/A
- MVIS N/A
- Revenue Growth
- ETON 23.29
- MVIS N/A
- 52 Week Low
- ETON $3.11
- MVIS $0.80
- 52 Week High
- ETON $18.41
- MVIS $1.95
- Technical
- Relative Strength Index (RSI)
- ETON 57.21
- MVIS 44.89
- Support Level
- ETON $13.53
- MVIS $1.07
- Resistance Level
- ETON $14.40
- MVIS $1.32
- Average True Range (ATR)
- ETON 0.97
- MVIS 0.11
- MACD
- ETON 0.32
- MVIS -0.00
- Stochastic Oscillator
- ETON 96.19
- MVIS 50.00
About ETON Eton Pharmaceuticals Inc.
Eton Pharmaceuticals Inc is a United States based specialty pharmaceutical company. The company is engaged in developing and commercializing pharmaceutical products to fulfill an unmet patient need. It has four commercial rare disease products, Alkindi Sprinkle for the treatment of adrenocortical insufficiency; Carglumic Acid for the treatment of hyperammonemia, Betaine Anhydrous for the treatment of homocystinuria; and Nitisinone for the treatment of hereditary tyrosinemia type 1 (HT-1). The Company has three additional product candidates in late-stage development: ET-400, ET-600, and ZENEO hydrocortisone autoinjector.
About MVIS MicroVision Inc.
Microvision Inc is engaged in developing a lidar sensor to be used in automotive safety and autonomous driving applications. Its lidar sensor uses laser beam scanning (LBS) technology, which is based on systems that include micro-electrical mechanical systems (MEMS), laser diodes, opto-mechanics, electronics, algorithms, and software. The company has also developed solutions for Augmented Reality, Interactive Displays, and Consumer Lidars.